Children's Hospital Srebrnjak
10
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
10%
1 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease
Role: lead
Evidence Driven Indoor Air Quality Improvement
Role: lead
Evaluation of the Effectiveness of Standard and Innovative Products That Represent a Substitute Meal for Weight Management in a Reduction Diet in Obese Participants With Asthma
Role: lead
Evaluation of the Effectiveness of Standard and Innovative Products That Represent a Substitute Meal for Weight Management in a Reduction Diet
Role: lead
Development of Personalized Balanced Nutrition Concept Through an IT Platform
Role: lead
Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis
Role: lead
Early Detection of COPD Patients in GOLD 0 (Smokers) Population
Role: lead
Confounding Factors of Impedance Pneumography
Role: collaborator
Impedance Pneumography Measurement During Acute Airway Obstruction and Recovery Phase in Young Children
Role: collaborator
Variability of Impedance Pneumography Tidal Breathing Flow-volume Curves During Sleep in Healthy Children
Role: collaborator
All 10 trials loaded